Research News
Physician-researchers at the George Washington University published a review suggesting that telehealth interventions are associated with improved obstetric outcomes.
Research from the George Washington University has found that apolipoprotein A-I binding protein restricts HIV-1 replication by targeting lipid rafts and reducing virus-cell fusion.
The outcomes for patients in their 80s who received carotid endarterectomy (CEA) surgery to reduce the risk of stroke are comparable to those of younger patients, according to a study by George Washington University (GW) researchers published in the Journal of Vascular Surgery.
The George Washington University (GW) School of Medicine and Health Sciences (SMHS) is investing $3.9 million to convert 13,500 square feet of lab space in Ross Hall into state-of-the-art research facilities.
A new survey from dermatology and emergency medicine researchers at GW suggests that the dermatology community is inadequately prepared for a biological disaster and would benefit from a formal preparedness training program.
Researchers at the George Washington University Advanced Metrics Lab found that a hip fracture patient’s length of stay in a rehabilitation facility has a greater impact on functional independence than therapy time per day.
Promoting self-directed learning (SDL) can be beneficial for medical student education, and a study published in Medical Science Educator by Pritha Ghosh, MD, assistant professor of neurology at the George Washington University (GW) School of Medicine and Health Sciences, offers curriculum design…
The Cutaneous Oncology Program at the GW Cancer Center was selected as the first global site for a clinical trial for patients with high-risk cutaneous squamous cell carcinoma.
A new study from Jonathan Silverberg, MD, PhD, MPH, maternal depression in the postpartum period, and even beyond, is associated with the development of atopic dermatitis throughout childhood and adolescence.
A recent study determined that the Collaborative National Quality and Efficacy Registry for scleroderma, or systemic sclerosis, is a powerful tool in guiding research and treatment development for the disease.